Adding these results to our previous study [33] makes us conclude that these compounds profoundly inhibit IGF-1R and impair MAPK and Akt pro-survival signaling, ultimately leading to activation of the intrinsic apoptotic pathway specifically in tumor cells which merits further in vivo validations in NSCLC xenografts. Here, AKT1 is linked to non-small cell lung carcinoma.